Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-59 of 59 for leukemia

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Hairy Cell Leukemia Patient Data Registry

    Rochester, MN

  2. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    Albert Lea, MN, Eau Claire, WI, La Crosse, WI, Mankato, MN

  3. Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL

    Jacksonville, FL, Rochester, MN

  4. Global Trial in APG2575 for Patients With CLL/​SLL

    Jacksonville, FL

  5. Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS

    Rochester, MN, La Crosse, WI, Eau Claire, WI, Mankato, MN

  6. A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, or 7+3 in Patients With AML

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

    Rochester, MN

  8. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR)

    Rochester, MN

  9. A Study of Leukemia Inhibitory Factor Biomarker Monitoring Progression and Treatment Response of Locally-advanced Unresectable and Metastatic Pancreatic Cancer Therapies

    Jacksonville, FL

.

Mayo Clinic Footer